Immutep Limited American Depositary Shares logo

IMMP Earnings Date: Feb 25, 2027 (Estimated) — Immutep Limited American Depositary Shares

XNAS

Updated

Price $3.36
Market Cap $495.2M
P/E —
52W Range $3.04 – $70.60
Next Earnings · Before open (est.)

When is IMMP's next earnings date?

Immutep Limited American Depositary Shares (IMMP) is expected to report H1 2027 earnings on Thursday, February 25, 2027 at 8:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company.

How did IMMP do in its last earnings report?

In its most recent report on Aug 30, 2026, Immutep Limited American Depositary Shares posted EPS of -$66.98 versus the -$10.32 estimate, a miss of 549.0%. Revenue was $10.3M against a $11.7M estimate. The stock's 1-day post-earnings move was -3.9%.

How much does IMMP stock move after earnings?

IMMP beat EPS estimates in 3 of its last 4 reported quarters. Over the last 5 reports the stock moved an average of 2.2% (up or down) in the day after earnings.

About Immutep Limited American Depositary Shares

Immutep Ltd is a clinical-stage biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate the body's immune response to fight cancer or suppress the immune system to treat autoimmune disease. The company is focused on advancing its product candidate, eftilagimod alfa (efti), through its registrational Phase three clinical trial towards marketing approval in first-line non-small cell lung cancer (1L NSCLC). The other product candidates in its portfolio include TACTI-003, AIPAC-003, TACTI-002, INSIGHT-005, and others, being developed as potential therapies for various cancers and autoimmune diseases.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-08-30-10.32-66.98-548.99%$10.3M❌ Miss-3.94%-4.23%-38.19%
2024-10-22FY 2024—-0.40—$0—+0.78%-1.03%+4.39%
2024-02-29H1 2024—-0.20—$0—+2.63%+19.74%+2.19%
2023-08-30FY 2023—-89.40—$5.2M—+1.60%+2.14%+1.60%
2023-02-27H1 2023—-0.40—$2.6M—-1.81%+5.72%+0.00%
2022-07-27-59.20-4.98—$702,840✅ Beat———
2022-02-22-92.00-5.49—$1.5M✅ Beat———
2021-08-30-152.00-39.02—$1.2M✅ Beat———

Showing last 8 quarters.

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .